Comparative analysis of antibodies and lymphocytes in pulmonary tuberculosis patients with negative and positive cultures.

INTRODUCTION The sputum smear or the culture are the definitive diagnosis of pulmonary tuberculosis. Only a fraction of clinical patients are culture-confirmed. METHODOLOGY A total of 24 clinical cases (40 ± 14 years old) with positive smear and negative co-morbidity were studied. Cases were selected from 600 patients who attended the pneumology service over two years. A sputum sample was cultured in Löwenstein-Jensen medium with consequent amplification of the rrnA V2 promoter, the differentiation region 4, and the IS6110 insertion sequence of Mycobacterium tuberculosis. After the culture result, the patients were divided into negative (n = 14) or positive (n = 10) culture groups. In addition, 30 samples from healthy donors (45 ± 10 years) were studied. The numbers of CD4, CD8 and CD19 lymphocytes were determined by flow cytometry. Levels of IgA and IgG to M. tuberculosis were measured by ELISA. RESULTS IgG and IgA levels were detected in patients with positive culture, while only IgA was found in patients with negative cultures. The lymphocyte populations in the two groups were similar.  The presence of a pleural apical cap was found more frequently in patients with negative- (57%) than with positive cultures (10%). CONCLUSIONS The isotype profile in patients with positive cultures was both IgA and IgG positive, while in patients with negative culture, only IgA was found. The results will contribute to improve the diagnostic algorithm and appropriate treatment of patients with clinical tuberculosis. Further studies are needed to determine if this profile is predictive of the outcome of isolation.

[1]  J. Sifuentes-Osornio,et al.  Mycobacterium tuberculosis complex bacteremia among HIV and non-HIV patients in a Mexican tertiary care center , 2018, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[2]  A. Hernández-Solís,et al.  Nontuberculous mycobacteria in clinical samples with negative acid-fast bacilli , 2017, International journal of mycobacteriology.

[3]  P. Cudahy,et al.  Diagnostics for pulmonary tuberculosis , 2016, Postgraduate medical journal.

[4]  J. Dunn,et al.  Laboratory Diagnosis of Mycobacterium tuberculosis Infection and Disease in Children , 2016, Journal of Clinical Microbiology.

[5]  T. Ottenhoff,et al.  IFN-γ and IgA against non-methylated heparin-binding hemagglutinin as markers of protective immunity and latent tuberculosis: Results of a longitudinal study from an endemic setting. , 2016, The Journal of infection.

[6]  R. Nicholson,et al.  IgG, IgM and IgA antibodies against the novel polyprotein in active tuberculosis , 2014, BMC Infectious Diseases.

[7]  T. Ottenhoff,et al.  IgA Response to ESAT‐6/CFP‐10 and Rv2031 Antigens Varies in Patients With Culture‐Confirmed Pulmonary Tuberculosis, Healthy Mycobacterium tuberculosis–Infected and Non‐Infected Individuals in a Tuberculosis Endemic Setting, Ethiopia , 2013, Scandinavian journal of immunology.

[8]  F. Cazarez,et al.  Skin biopsy: a pillar in the identification of cutaneous Mycobacterium tuberculosis infection. , 2012, Journal of infection in developing countries.

[9]  C. Litwin,et al.  Antituberculosis IgG Antibodies as a Marker of Active Mycobacterium tuberculosis Disease , 2012, Clinical and Vaccine Immunology.

[10]  T. Victor,et al.  Tuberculosis assays: past, present and future , 2011, Expert review of anti-infective therapy.

[11]  F. Al-Zamel.  Detection and diagnosis of Mycobacterium tuberculosis , 2009, Expert review of anti-infective therapy.

[12]  R. Hernández-Pando,et al.  Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infection. , 2009, International journal of medical microbiology : IJMM.

[13]  G. Bjune,et al.  The protective role of antibody responses during Mycobacterium tuberculosis infection , 2009, Clinical and experimental immunology.

[14]  O. Leite,et al.  A study of IgA antibody response to different mycobacterium tuberculosis antigens in the diagnosis and monitoring of pulmonary tuberculosis. , 2009, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[15]  B. L. Anderson,et al.  Assessment of Three Commercially Available Serologic Assays for Detection of Antibodies to Mycobacterium tuberculosis and Identification of Active Tuberculosis , 2008, Clinical and Vaccine Immunology.

[16]  Daniel Brodie,et al.  The diagnosis of tuberculosis. , 2005, Clinics in chest medicine.

[17]  Mahavir Singh,et al.  Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs , 2004, Immunology.

[18]  M. Conde,et al.  Immunoglobulin A (IgA) and IgG Immune Responses against P-90 Antigen for Diagnosis of Pulmonary Tuberculosis and Screening for Mycobacterium tuberculosis Infection , 2004, Clinical Diagnostic Laboratory Immunology.

[19]  J. Gonzalez-Y-Merchand,et al.  A novel multiplex-PCR for the rapid identification of Mycobacterium bovis in clinical isolates of both veterinary and human origin , 2003, Epidemiology and Infection.

[20]  G. Rook,et al.  Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection , 2000, The Lancet.

[21]  A. Escobar-Gutiérrez,et al.  Enzyme-linked immunosorbent assay (ELISA) with mycobacterial crude antigens for the sero-epidemiological diagnosis of active tuberculosis. , 1996, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.